Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

luciferase siRNA/HBV ribozyme/folate-conjugated hybrid phi29 pRNA 3WJ domain nanoparticles

Based on

1 Articles
2014 Most recent source

Composition

1

luciferase siRNA gene-conjugated phi29 pRNA 3WJ domain strain A

Type Biomolecule
Formula
Role raw materials
2

luciferase siRNA gene-conjugated-conjugated phi29 pRNA 3WJ domain strain B

Type Biomolecule
Formula
Role raw materials
3

HBV ribozyme gene-conjugated phi29 pRNA 3WJ domain strain C

Type Biomolecule
Formula
Role raw materials
4

2'-deoxy-2'-fluoro-U/C-modified phi29 pRNA 3WJ domain strain D

Type Biomolecule
Formula
Role raw materials
5

RNA

Type Biomolecule
Formula
Role raw materials

Properties

Applications

Area Application Nanomaterial Variant Source
nanobiotechnology

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
atomic force microscopy

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
KB cells

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • luciferase siRNA gene-conjugated phi29 pRNA 3WJ domain strain A
  • TMS buffer
  • 2'-deoxy-2'-fluoro-U/C-modified phi29 pRNA 3WJ domain strain D
See all (6)
Product

luciferase siRNA/HBV ribozyme/folate-conjugated hybrid phi29 pRNA 3WJ domain nanoparticles

Edge: ~ 13 nm

Medium: TMS buffer

Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial